BiPER Therapeutics
My visitor profile
BiPER Therapeutics
Description of your activity
- BiPER Therapeutics develop first-in-class selective BiP inhibitors to treat cancers
More information
Emerging company
Mehdi CHELBI
CEO
Date of your company creation:
- Between 3 & 5 years
Main sector
- Biotechnology - Therapeutics and Diagnostics
Address
- Country : FRANCE
- City : STRASBOURG
- Zip Code : 67000
Participation objectives
Partnering objectives
- Out-licensing / collaboration opportunities, Financing / investment opportunities